Nucleic Acid Delivery

Precision Peptide Conjugates for Nucleic Acid Delivery

Orbit Discovery’s platform offers a novel approach to discovering peptide conjugates for targeted RNA delivery.

Using proprietary bead-based technology, we efficiently identify peptides with strong affinities for disease-specific targets, ensuring precise delivery to desired cells. Validation of hits includes using micro-arrays to show specificity and internalisation studies to show peptides being actively transported into the cells.
‍
Orbit Discovery’s flexible design and advanced screening technology accelerate the development of nucleic acid conjugates for your targeted nucleic acid therapies.

Features

High Affinity for Tumor Specific Targets

‍
Discover and optimize peptide conjugates with high affinity for tumor-specific cell surface markers, ensuring accurate radionuclide delivery.

Massive Library Diversity

‍
Build superlarge peptide libraries tailored for radionuclide delivery, offering a wide array of chemistries, structures, and affinities.

Streamlined Conjugate Development

‍
Accelerate the discovery process with FACS-based screening, identifying and refining low affinity binders for fast optimization.

From Hit to Lead

‍
Opitimise and expand your hit with access to Orbit's peptide chemistry expertise. Test for internalisation, chelators, linkers and essential binding motifs to turn your hit peptide to a lead.